SMIC (00981.HK) fell 6.29% to HKD 46.820; its 8-inch utilisation hit 95.8% in Q3, and Samsung's Giheung fab shutdown will cut 50,000 wafers of monthly capacity.
UBTECH ROBOTICS (09880.HK) fell 4.31% to HKD 64.450; it signed a Ras Al Khaimah government MoU, and Tesla said Optimus could be sold externally by end-2027.
As of 10:34 on October 22, Db X-Trackers FTSE Vietnam UCITS ETF (03087.HK) rose 0.90% to HKD 303.200, with a turnover of approximately HKD 312,200 and assets under management of approximately HKD 2.625 billion.
Jiangsu Xinde passed the HKEX listing hearing on Oct 21, with Huatai International as sole sponsor. 2025 revenue hit RMB1,012.2m, ranked 7th in China OSATs.
On 21 October 2026, ROBOSENSE (02498.HK) said Shenzhen RoboSense will lend up to RMB 10 million each to Qiu Chunxin and Liu Letian, at 3.00% per annum.
On 22 October 2026, VCREDIT (02003.HK) received court rulings from two Weinan courts over insurer payments, with RMB 313 million of a unit's funds frozen.
On 22 October 2026, TENCENT (00700.HK) said it completed a four-tranche note issuance on 21 October 2026, raising USD 1.8 billion and RMB 26 billion in total.
On 21 October 2026, DEEPZERO (02723.HK) signed an MOU with Huawei Cloud to build joint AI marketing solutions, with pilots starting in auto and retail.
On 21 October 2026, ITC Neocloud(00199.HK) set up an AI business committee chaired by executive director Cao Xinwei, as its AIDC projects progress.
On 21 October 2026, XJ INTL HLDGS (01765.HK) said unit Nanchong Xinqi won a 34,812.40 sq m residential plot in Nanchong, Sichuan for about RMB 115.4 million.
On 22 October 2026, UISEE TECH (01511.HK) supplied driver assistance software for the new Buick LaCrosse and Cadillac XT5, reusing one platform across models.
On 22 October 2026, BLOKS (00325.HK) said Smart Bloks sold 3,849,000 shares at HK$ 65.28 each, cutting its stake from 3.57% to 2.01% and Zhu Weisong's to 52.03%.
On 21 October 2026, SHIMAO GROUP (00813.HK) said receivers will sell the hotel and business to Oceanfront Hong Kong for HK$ 2.7 billion, closing by end-2026.
On 21 Oct 2026, XUANZHUBIO-B (02575.HK) said Phase III data showed anlarazole sodium met its endpoint in reflux oesophagitis, with 88.4% healing in FAS.
On 21 Oct 2026, KINTOR PHARMA-B (09939.HK) said its KT-939 inhibitor won a Chinese invention patent grant notice; an NMPA cosmetic filing was filed on 18 Sept.
On 21 Oct 2026, WELLCELL HOLD (02477.HK) said substantial shareholder Hang Fung sold 716mn shares, about 14.93% of the company, for roughly HK$107mn.
